AstraZeneca Says Wainua Trial Failed to Meet Primary Goal
The drug trial for a rare type of heart disease showed the treatment was generally well tolerated but it did not work better than a placebo.
China's Zhipu AI Shares Surge on $4 Billion Fundraising
Shares of the Chinese artificial-intelligence company rose sharply after it announced plans for a US$4 billion fundraising to support growth, despite pricing the new shares at a discount.
The $80 Billion Debt Cloud Hanging Over David Ellison's Warner Deal
